BMT Stock Overview
Develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Beamtree Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.24 |
52 Week High | AU$0.28 |
52 Week Low | AU$0.17 |
Beta | 1.78 |
1 Month Change | 40.00% |
3 Month Change | 13.95% |
1 Year Change | -14.04% |
3 Year Change | -41.67% |
5 Year Change | n/a |
Change since IPO | 36.11% |
Recent News & Updates
A Piece Of The Puzzle Missing From Beamtree Holdings Limited's (ASX:BMT) 31% Share Price Climb
May 10Recent updates
A Piece Of The Puzzle Missing From Beamtree Holdings Limited's (ASX:BMT) 31% Share Price Climb
May 10Beamtree Holdings Limited (ASX:BMT) Might Not Be As Mispriced As It Looks
Jul 27Is Now The Time To Look At Buying Beamtree Holdings Limited (ASX:BMT)?
Apr 05Estimating The Intrinsic Value Of Beamtree Holdings Limited (ASX:BMT)
Feb 06A Look At The Fair Value Of PKS Holdings Limited (ASX:PKS)
Feb 05Can PKS Holdings Limited (ASX:PKS) Improve Its Returns?
Jan 01If You Had Bought PKS Holdings (ASX:PKS) Stock A Year Ago, You Could Pocket A 115% Gain Today
Nov 23Shareholder Returns
BMT | AU Healthcare Services | AU Market | |
---|---|---|---|
7D | 4.3% | -1.3% | 1.1% |
1Y | -14.0% | 74.2% | 9.4% |
Return vs Industry: BMT underperformed the Australian Healthcare Services industry which returned 69% over the past year.
Return vs Market: BMT underperformed the Australian Market which returned 8.7% over the past year.
Price Volatility
BMT volatility | |
---|---|
BMT Average Weekly Movement | 10.1% |
Healthcare Services Industry Average Movement | 8.7% |
Market Average Movement | 9.0% |
10% most volatile stocks in AU Market | 17.4% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: BMT's share price has been volatile over the past 3 months.
Volatility Over Time: BMT's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 95 | Tim Kelsey | beamtree.com.au |
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records.
Beamtree Holdings Limited Fundamentals Summary
BMT fundamental statistics | |
---|---|
Market cap | AU$70.45m |
Earnings (TTM) | -AU$5.68m |
Revenue (TTM) | AU$25.22m |
2.8x
P/S Ratio-12.4x
P/E RatioIs BMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BMT income statement (TTM) | |
---|---|
Revenue | AU$25.22m |
Cost of Revenue | AU$21.89m |
Gross Profit | AU$3.33m |
Other Expenses | AU$9.01m |
Earnings | -AU$5.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.02 |
Gross Margin | 13.19% |
Net Profit Margin | -22.54% |
Debt/Equity Ratio | 1.1% |
How did BMT perform over the long term?
See historical performance and comparison